Skip to main content
Top
Published in: Rheumatology International 8/2012

01-08-2012 | Short Communication

−383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study

Authors: Esther Guadalupe Corona-Sanchez, José Francisco Muñoz-Valle, Laura Gonzalez-Lopez, Julia Dolores Sanchez-Hernandez, Monica Vazquez-Del Mercado, Heriberto Ontiveros-Mercado, Miguel Huerta, Xochitl Trujillo, Alberto Daniel Rocha-Muñoz, Alfredo Celis, Ricardo Ortega-Flores, Jorge Ivan Gamez-Nava

Published in: Rheumatology International | Issue 8/2012

Login to get access

Abstract

The objective of this study was to evaluate the differences in allele and genotype frequencies of −383 tumor necrosis factor receptor 1 (TNFR1) polymorphism between ankylosing spondylitis (AS) and controls. Mexican Mestizos with AS were matched by gender, age, and ethnicity with healthy controls and compared in allele and genotype frequencies of the −383 TNFR1 polymorphism. Polymorphisms were genotyped using PCR–RFLP. The AA genotype occurred at a higher frequency in the AS group (92%) compared with controls (79%, P = 0.03). A allele was increased in AS (96% vs. 88%, P = 0.015) and was associated with genetic susceptibility for AS (odds ratio = 3.48, 95% CI = 1.23–10.61). This preliminary study is the first assessing the association of the −383 A/C TNFR1 polymorphism with AS, although it has the limitation of a small sample size. These data are of interest for the genetic epidemiology of AS in the Mexican population, requiring further investigation in other countries.
Literature
1.
go back to reference Khan MA (1998) Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD (eds) The spondylarthritides. Oxford University, Oxford, pp 27–40 Khan MA (1998) Ankylosing spondylitis: clinical aspects. In: Calin A, Taurog JD (eds) The spondylarthritides. Oxford University, Oxford, pp 27–40
2.
go back to reference Liu Y, Cortinovis D, Stone MA (2004) Recent advances in the treatment of the spondyloarthropathies. Curr Opin Rheumatol 16:357–365PubMedCrossRef Liu Y, Cortinovis D, Stone MA (2004) Recent advances in the treatment of the spondyloarthropathies. Curr Opin Rheumatol 16:357–365PubMedCrossRef
3.
go back to reference Glossop JR, Dawes PT, Nixon NB, Mattey DL (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 7:R1227–R1234PubMedCrossRef Glossop JR, Dawes PT, Nixon NB, Mattey DL (2005) Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 7:R1227–R1234PubMedCrossRef
4.
go back to reference Dieudé P, Osorio J, Petit-Teixeira E et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413–419PubMedCrossRef Dieudé P, Osorio J, Petit-Teixeira E et al (2004) A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 50:413–419PubMedCrossRef
5.
go back to reference Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL (2003) No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 30:1406–1409PubMed Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL (2003) No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J Rheumatol 30:1406–1409PubMed
6.
go back to reference Pitts SA, Olomolaiye OO, Elson CJ, Westacott CI, Bidwell JL (1998) Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I(p55) gene. Eur J Immunogenet 25:271–272PubMed Pitts SA, Olomolaiye OO, Elson CJ, Westacott CI, Bidwell JL (1998) Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I(p55) gene. Eur J Immunogenet 25:271–272PubMed
7.
go back to reference Nishimura M, Obayashi H, Mizuta I et al (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64:302–309PubMedCrossRef Nishimura M, Obayashi H, Mizuta I et al (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64:302–309PubMedCrossRef
8.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
9.
go back to reference Vargas-Alarcon G, Casasola-Vargas J, Rodríguez-Pérez JM et al (2006) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826–832PubMedCrossRef Vargas-Alarcon G, Casasola-Vargas J, Rodríguez-Pérez JM et al (2006) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826–832PubMedCrossRef
10.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
11.
go back to reference Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
12.
go back to reference Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946–950PubMed Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946–950PubMed
13.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
14.
go back to reference Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34:668–677PubMedCrossRef Davis JC Jr (2005) Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis. Semin Arthritis Rheum 34:668–677PubMedCrossRef
15.
go back to reference Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045–2050PubMedCrossRef Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045–2050PubMedCrossRef
16.
go back to reference Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA (2009) The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27:645–648PubMed Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA (2009) The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol 27:645–648PubMed
17.
go back to reference Australo-Anglo-American Spondyloarthritis Consortium, TASC (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127CrossRef Australo-Anglo-American Spondyloarthritis Consortium, TASC (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127CrossRef
18.
go back to reference Davidson SI, Liu Y, Danoy PA et al (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70:289–292PubMedCrossRef Davidson SI, Liu Y, Danoy PA et al (2011) Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 70:289–292PubMedCrossRef
Metadata
Title
−383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study
Authors
Esther Guadalupe Corona-Sanchez
José Francisco Muñoz-Valle
Laura Gonzalez-Lopez
Julia Dolores Sanchez-Hernandez
Monica Vazquez-Del Mercado
Heriberto Ontiveros-Mercado
Miguel Huerta
Xochitl Trujillo
Alberto Daniel Rocha-Muñoz
Alfredo Celis
Ricardo Ortega-Flores
Jorge Ivan Gamez-Nava
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1997-5

Other articles of this Issue 8/2012

Rheumatology International 8/2012 Go to the issue